Literature DB >> 30258542

SAR of 4-Alkoxybenzoic Acid Inhibitors of the Trypanosome Alternative Oxidase.

Alejandro Meco-Navas1, Godwin U Ebiloma2,3, Ana Martín-Domínguez1, Irene Martínez-Benayas1, Eduardo J Cueto-Díaz1, Amani Saud Alhejely2, Emmanuel O Balogun4, Machi Saito3, Miho Matsui3, Natsumi Arai3, Tomoo Shiba3, Shigeharu Harada3, Harry P de Koning2, Christophe Dardonville1.   

Abstract

The SAR of 4-hydroxybenzaldehyde inhibitors of the trypanosome alternative oxidase (TAO), a critical enzyme for the respiration of bloodstream forms of trypanosomes, was investigated. Replacing the aldehyde group with a methyl ester resulted in a 10-fold increase in TAO inhibition and activity against T. brucei. Remarkably, two analogues containing the 2-hydroxy-6-methyl scaffold (9e and 16e) displayed single digit nanomolar TAO inhibition, which constitute the most potent 4-alkoxybenzoic acid derivatives described to date. 9e was 50-times more potent against TAO and 10-times more active against T. brucei compared to its benzaldehyde analogue 1. The farnesyl derivative 16e was as potent a TAO inhibitor as ascofuranone with IC50 = 3.1 nM. Similar to ascofuranone derivatives, the 2-hydroxy and 6-methyl groups seemed essential for low nanomolar TAO inhibition of acid derivatives, suggesting analogous binding interactions with the TAO active site.

Entities:  

Year:  2018        PMID: 30258542      PMCID: PMC6142067          DOI: 10.1021/acsmedchemlett.8b00282

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  23 in total

1.  Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration.

Authors:  Robert Ott; Kelly Chibale; Sedrick Anderson; Alex Chipeleme; Minu Chaudhuri; Abdelmadjid Guerrah; Nancy Colowick; George C Hill
Journal:  Acta Trop       Date:  2006-11-28       Impact factor: 3.112

2.  Mitsunobu and related reactions: advances and applications.

Authors:  K C Kumara Swamy; N N Bhuvan Kumar; E Balaraman; K V P Pavan Kumar
Journal:  Chem Rev       Date:  2009-06       Impact factor: 60.622

3.  The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice.

Authors:  Yoshisada Yabu; Ayako Yoshida; Takashi Suzuki; Coh-ichi Nihei; Keisuke Kawai; Nobuko Minagawa; Tomoyoshi Hosokawa; Kazuo Nagai; Kiyoshi Kita; Nobuo Ohta
Journal:  Parasitol Int       Date:  2003-06       Impact factor: 2.230

4.  Readily functionalizable phosphonium-tagged fluorescent coumarins for enhanced detection of conjugates by mass spectrometry.

Authors:  Antoine Lizzul-Jurse; Laetitia Bailly; Marie Hubert-Roux; Carlos Afonso; Pierre-Yves Renard; Cyrille Sabot
Journal:  Org Biomol Chem       Date:  2016-08-10       Impact factor: 3.876

Review 5.  The trypanosome alternative oxidase: a potential drug target?

Authors:  Stefanie K Menzies; Lindsay B Tulloch; Gordon J Florence; Terry K Smith
Journal:  Parasitology       Date:  2016-11-29       Impact factor: 3.234

6.  Biochemical characterization of highly active Trypanosoma brucei gambiense glycerol kinase, a promising drug target.

Authors:  Emmanuel Oluwadare Balogun; Daniel Ken Inaoka; Tomoo Shiba; Yasutoshi Kido; Takeshi Nara; Takashi Aoki; Teruki Honma; Akiko Tanaka; Masayuki Inoue; Shigeru Matsuoka; Paul A M Michels; Shigeharu Harada; Kiyoshi Kita
Journal:  J Biochem       Date:  2013-04-25       Impact factor: 3.387

7.  Respiration of bloodstream forms of the parasite Trypanosoma brucei brucei is dependent on a plant-like alternative oxidase.

Authors:  A B Clarkson; E J Bienen; G Pollakis; R W Grady
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

8.  Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.

Authors:  Enock Matovu; Mhairi L Stewart; Federico Geiser; Reto Brun; Pascal Mäser; Lynsey J M Wallace; Richard J Burchmore; John C K Enyaru; Michael P Barrett; Ronald Kaminsky; Thomas Seebeck; Harry P de Koning
Journal:  Eukaryot Cell       Date:  2003-10

9.  Pharmacophore identification of ascofuranone, potent inhibitor of cyanide-insensitive alternative oxidase of Trypanosoma brucei.

Authors:  Hiroyuki Saimoto; Yasutoshi Kido; Yasushi Haga; Kimitoshi Sakamoto; Kiyoshi Kita
Journal:  J Biochem       Date:  2012-11-23       Impact factor: 3.387

10.  Trypanocidal action of bisphosphonium salts through a mitochondrial target in bloodstream form Trypanosoma brucei.

Authors:  Abdulsalam A M Alkhaldi; Jan Martinek; Brian Panicucci; Christophe Dardonville; Alena Zíková; Harry P de Koning
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-12-11       Impact factor: 4.077

View more
  3 in total

1.  Identification of megacerotonic acid and a quinazoline derivative from Universal Natural Product Database as potential inhibitors of Trypanosoma brucei brucei alternative oxidase: molecular docking, molecular dynamic simulation and MM/PBSA analysis.

Authors:  Rahma Muhammad Adamu; Bashiru Ibrahim; Mohammed Auwal Ibrahim; Emmanuel Oluwadare Balogun
Journal:  J Biomol Struct Dyn       Date:  2021-11-23       Impact factor: 5.235

2.  Imidazoline- and Benzamidine-Based Trypanosome Alternative Oxidase Inhibitors: Synthesis and Structure-Activity Relationship Studies.

Authors:  David Cisneros; Eduardo J Cueto-Díaz; Tania Medina-Gil; Rebecca Chevillard; Teresa Bernal-Fraile; Ramón López-Sastre; Mustafa M Aldfer; Marzuq A Ungogo; Hamza A A Elati; Natsumi Arai; Momoka Otani; Shun Matsushiro; Chiaki Kojima; Godwin U Ebiloma; Tomoo Shiba; Harry P de Koning; Christophe Dardonville
Journal:  ACS Med Chem Lett       Date:  2022-01-28       Impact factor: 4.345

3.  Investigation of 5'-Norcarbocyclic Nucleoside Analogues as Antiprotozoal and Antibacterial Agents.

Authors:  Anastasia L Khandazhinskaya; Elena S Matyugina; Pavel N Solyev; Maggie Wilkinson; Karen W Buckheit; Robert W Buckheit; Larisa N Chernousova; Tatiana G Smirnova; Sofya N Andreevskaya; Khalid J Alzahrani; Manal J Natto; Sergey N Kochetkov; Harry P de Koning; Katherine L Seley-Radtke
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.